Investors should not panic amid the current oil supply disruption but should ensure they have diversified inflation hedges in their portfolios, Sebastian Page, head of global multi-asset and chief investment officer at T. Rowe Price, said. Page, who oversees more than $500B in assets for the firm, told CNBC that while the Strait of Hormuz crisis will eventually end, the uncertainty around timing m...
Investors should not panic amid the current oil supply disruption but should ensure they have diversified inflation hedges in their portfolios, Sebastian Page, head of global multi-asset and chief investment officer at T. Rowe Price, said. Page, who oversees more than $500B in assets for the firm, told CNBC that while the Strait of Hormuz crisis will eventually end, the uncertainty around timing makes proper hedging essential. In the interview with CNBC, Page acknowledged the unprecedented nature of the current supply shock. “There’s no historical playbook for this kind of supply disruption,” he said, noting that forecasts for when the Strait of Hormuz will reopen vary widely. While some betting markets suggest a 40% chance of reopening by April, other professional forecasters give only a 1% probability of reopening by April 10 and a 60% chance the crisis extends beyond May. Page emphasized that T. Rowe Price is not dramatically shifting its investment strategy despite the turmoil. “In our asset allocation committee, we actually went into this: hedging for inflation risk, neutral between stocks and bonds, and long diversification,” he explained. The firm maintains overweight positions in small caps and international non-U.S. equities, viewing small-cap valuations as “a coiled spring” ready to benefit once the crisis passes. The CIO outlined his firm’s approach to navigating the current environment. “To get through this, we have been hedging for inflation, long real-asset equities, stocks of commodity-linked companies, and energy companies,” Page said. He also noted the firm is short duration, holding more cash than long bonds, and suggested investors without commodity exposure should consider adding it to their portfolios. Page challenged the conventional wisdom that Treasury bonds are sufficient portfolio hedges. “People think treasuries hedge a portfolio. Well, they don’t if you get an inflation shock,” he warned. His key message for investors: “Diversify your hed...
200mm/E+ via Getty Images An Israeli strike on Iran’s Caspian Sea port of Bandar Anzali disrupted a key supply route used by Russia and Iran to transfer weapons, including drones and ammunition, The Wall Street Journal reported Wednesday, citing people familiar with the situation. The attack, Israel’s first in the inland sea, hit naval facilities, vessels and infrastructure tied to military logist...
200mm/E+ via Getty Images An Israeli strike on Iran’s Caspian Sea port of Bandar Anzali disrupted a key supply route used by Russia and Iran to transfer weapons, including drones and ammunition, The Wall Street Journal reported Wednesday, citing people familiar with the situation. The attack, Israel’s first in the inland sea, hit naval facilities, vessels and infrastructure tied to military logistics. The Caspian corridor has been a critical link for moving Iranian drones and munitions to Russia, while also supporting broader trade between the two countries. The strike highlights growing cooperation between Moscow and Tehran during the war, as well as Israel’s efforts to disrupt those ties. It may also have knock-on effects for civilian supply chains, including food and energy, given the overlap between military and commercial shipping in the region. While the operation could temporarily slow weapons flows, analysts expect Russia and Iran to reroute shipments through alternative channels. Moscow condemned the attack, warning against further escalation in the Caspian, the Journal reported. More news and analysis Portillo's: Macroeconomic And Technical Caution Outweigh Valuation Markets Are About To Bounce Higher: 3 Stocks I'm Doubling Down On BlackRock Energy Opportunities Fund Q4 2025 Commentary YieldMax Gold Miners Option Income Strategy ETF announces weekly distribution of $0.1295 Sarepta gains on data for muscular dystrophy therapies
(RTTNews) - Tower Semiconductor Ltd. (TSEM), Wednesday announced a strategic move to restructure its Japan operations, which are currently run through TPSCo, a Japanese company owned 51 percent by Tower and 49 percent by Nuvoton Technology Corporation Japan.
(RTTNews) - Tower Semiconductor Ltd. (TSEM), Wednesday announced a strategic move to restructure its Japan operations, which are currently run through TPSCo, a Japanese company owned 51 percent by Tower and 49 percent by Nuvoton Technology Corporation Japan.
EzumeImages/iStock via Getty Images In the months that followed my most recent analysis , Portillo’s, Inc. ( PTLO ) showed some price recovery with 13% returns, which justifies my buy rating before. But today, we may be seeing more headwinds as the macroeconomic environment becomes more volatile amid stubborn inflation and rising oil prices. The market landscape is also becoming increasingly compe...
EzumeImages/iStock via Getty Images In the months that followed my most recent analysis , Portillo’s, Inc. ( PTLO ) showed some price recovery with 13% returns, which justifies my buy rating before. But today, we may be seeing more headwinds as the macroeconomic environment becomes more volatile amid stubborn inflation and rising oil prices. The market landscape is also becoming increasingly competitive as pricing strategies and promotion from big peers like McDonald’s ( MCD ) may threaten its sales. The consolation is that its fundamentals still appear strategically positioned to ensure sustainability. Meanwhile, valuation appears to have already priced in new market risks, but technicals are still flat amid consolidation. Q4 2025: Sales Resilient, But Margin Compressed The restaurant industry grapples with real recovery as stubborn inflation and tariff woes continue to affect their pricing flexibility and even squeeze their margins. The impact used to be visible only among fast-food restaurants. But today, even many fast-casual restaurants may not be completely shielded as consumer spending softens. Portillo’s, Inc. may not be an exemption, although it continues to demonstrate its resilience in its most recent performance. In Q4 2025, its operating revenue amounted to $185.7M , up by 0.6% YoY from $184.6M. This was mainly due to its continued expansion through new restaurant openings. In fact, it already had 102 restaurants from 94 YoY. This shows its attempt to increase its domestic market presence and strengthen its brand popularity. However, this could not cover the consequences of unfavorable macroeconomic conditions. Its same-restaurant sales decreased 3.3%. This becomes more evident if we divide the revenue by the number of restaurants. On average, PTLO generated an average revenue of $1.82M ($185.7M / 102 restaurants) per restaurant, which is notably lower than $1.96M ($184.6M /94 restaurants) in the previous year. Restaurant Statistics (PTLO Q4 2025 Releas...
Jian Fan Sarepta Therapeutics ( SRPT ) added ~25% in the morning hours on Wednesday after the company posted initial data from Phase 1/2 trials for its experimental drugs targeted at two rare forms of muscular dystrophies. The company said that the results support the potential of SRP-1001 and SRP-1003, which are based on its small interfering RNA (siRNA) treatment platform. The treatments are des...
Jian Fan Sarepta Therapeutics ( SRPT ) added ~25% in the morning hours on Wednesday after the company posted initial data from Phase 1/2 trials for its experimental drugs targeted at two rare forms of muscular dystrophies. The company said that the results support the potential of SRP-1001 and SRP-1003, which are based on its small interfering RNA (siRNA) treatment platform. The treatments are designed to treat facioscapulohumeral muscular dystrophy type 1 (FSHD1) and myotonic dystrophy type 1 (DM1), respectively. According to Sarepta ( SRPT ), the results indicate that its αvβ6 integrin-targeted siRNA approach can lead to high muscle exposure of targeted treatments without dose-limiting toxicities. While RNA-targeted therapies have shown promise against FSHD and DM1, their efficacy has been limited due to rapid degradation inside the body before delivery to intended cells. “We are pleased that these early clinical results showed high levels of siRNA delivery to muscle, with no saturation of muscle siRNA uptake or dose-limiting safety signals to date,” said Louise Rodino-Klapac, Serepta’s ( SRPT ) President of R&D and technical operations. More on Sarepta Therapeutics Sarepta Therapeutics: A $2B Business Priced Like It's Broken Sarepta Therapeutics, Inc. (SRPT) Presents at TD Cowen 46th Annual Health Care Conference Transcript Sarepta Therapeutics, Inc. 2025 Q4 - Results - Earnings Call Presentation Sarepta to soon submit sNDAs for traditional approval for Duchenne treatments Sarepta Therapeutics begins search for CEO as Douglas Ingram announces retirement; shares down
The global PC market has clawed its way back from a brutal slump in 2022 and 2023, when shipments cratered amid post-pandemic oversupply, with 2024 delivering modest growth as businesses and consumers began refreshing aging fleets. By 2025, the rebound appeared to be accelerating sharply — shipments rose 9.3% year-over-year, fueled by commercial upgrades to ... RAMageddon Arrives: AI’s Endless App...
The global PC market has clawed its way back from a brutal slump in 2022 and 2023, when shipments cratered amid post-pandemic oversupply, with 2024 delivering modest growth as businesses and consumers began refreshing aging fleets. By 2025, the rebound appeared to be accelerating sharply — shipments rose 9.3% year-over-year, fueled by commercial upgrades to ... RAMageddon Arrives: AI’s Endless Appetite Just Killed the PC Comeback
Bria.ai, the Visual Generative AI Platform for developers and production studios, is proud to have been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2026. This year's list shines a spotlight on businesses that are shaping industry and culture through their innovations. Alongside the World's 50 Most Innovative Companies, Fast Company recognizes 720 honorees a...
Bria.ai, the Visual Generative AI Platform for developers and production studios, is proud to have been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2026. This year's list shines a spotlight on businesses that are shaping industry and culture through their innovations. Alongside the World's 50 Most Innovative Companies, Fast Company recognizes 720 honorees across 59 sectors and regions.